3. Pulmonary Pathology

!"#$%&'() !'+,%#%-) !'+,%#%-) *#'+,-"(+. ./0+("1+2%& 3"0"'##) ./0+("1+2%&  3"0"'##) $"1"04 5(676&+0 '2( 8(%$ (6'1,2&920+'# '2(:')0

;('5569 '2( -6+0 (60%(/69 < '#76%#'( 1%##'506 =(6>"6&+ 5%0+ %5 1%$5#21'+2%&

 !"#$#%"&'(' /+0-,#''(+. ?61,'&21'# 1%##'506 %8 '#76%#2

@"6 +% 5#6"('# 688"02%&0A 6#67'+2%& %8 +,6 92'5,('-$ '8+6( 0"(-6() %( '012+60 3/'0'# '012+60 3/'0'# '+6#61+'0204

/+.",&%"(+. B%1'# %( -6&6('#2C69 82/(%+21 3121'+(2C'+2%&4 1,'&-60 2& +,6 #"&- %( 5#6"(' ,'$56( 6D5'&02%& '&9 2&1(6'06 6#'0+21 (61%2# 9"(2&- 6D52('+2%& 32((676(02/#64

 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

!'+26&+0 +,'+ '(6 76() %#9A 065+21 %( 6D56(26&12&- $"#+2 %(-'& 8'2#"(6 ,'76 ' 5%%( 5(%-&%020A /"+ &%($'# 8"&1+2%& 1'& (6+"(& '8+6( _ ` F^ $%&+,0 I6%&'+'# U@P < 2&'96>"'+6 0"(8'1+'&+ #676#0 39288"06 -('&"#'(2+) %& TVU4 61$0+.&,2 7.8#%"(+.' 6.#10+.(& T%$5#21'+2%&0a E/01600A ]$5)6$'A .(-'&2C'+2%& 301'( +200"64A /'1+6(6$2'A (61"((6&+ 5&6"$%&2'0 !(2$'()a "0"'##) 2&861+0 ' ,6'#+,) 56(0%& :2+, ' 72("#6&+ %(-'&20$ b#6/026##'A ]S 1%#2 '&9 !06"9%$%&'0 '(6 $%0+ 1%$$%&#) 2&7%#769 2& ,%052+'# '1>"2(69 !IE 3-('$ `764 9+:&, 6.#10+.(& ;,+.% c2("#6&+ .(-'&20$0 B600 72("#6&+ %(-'&20$0 ?)1%5#'0$' 5&6"$%&2'6 < 1(%:969 PS 5&6"$%&2'6 3$%0+ 1%$$%& 1%$$"&2+) 2&0+2+"+2%&0N '00%12'+69 :2+, EMOE '1>"2(694 PS '"(6"0 < "0"'##) 0"56(2$5%069 %& ' 72('# T,#'$)92' 5&6"$%&2'6 bS 5&6"$%&2'6 < +,21K $"1%29 1'50"#6 '&9 2&861+2%& %8 +,6 dU;N 1'& /6 1%$5#21'+69 /) UPcA T?cA M&8#"6&C' 72("0 3< ^e P+'5,4 +200"6 9'$'-6 5(%9"16 ' (69 1"(('&+ R6##) '& '/01600 %( 6$5)6$' TS /"(&6+22 < f 8676( 2& 8'($6(0 '&9 76+0 05"+"$ 39"6 +% '052('+2%&4 < $%(6 OS 2&8#"6&C' < '00%12'+69 :2+, T.!@ 1%$$%& 2& 6#96(#)A '#1%,%#210 '&9 92'/6+210N !S '6("-2&%0' < T= 5'+26&+0 ]96$'A 2&8#'$$'+2%& X ,)56(6$2' 2& 065+' '/01600 ?S 1'+'((,'#20 < 1%$$"&2+) '&9 T.!@ /"+ +,6 #"$6& %8 +,6 '#76%#2 (6$'2&0 1#6'( BS 5&6"$%5,2#' < +('&0$2++69 8(%$ :'+6( P5(6'90 +,(%"-, 5%(60 %8 b%,& 0%"(160A 2&+('16##"#'( %(-'&20$ 302#76( 0+'2&4 @288"06 2&+6(0+2+2'# 2&82#+('+60 '556'( '0 2&1(6'069 #"&- $'(K2&-0 %& TVU I% +200"6 9'$'-6 < 1%$5#6+6 (61%76() M&+6(76&2&- +200"6 9'$'-6 [(6052('+%() 920+(600 %"+ %8 5(%5%(+2%& +% E1"+6 T%&-60+2%& < ,6'7)A (69 '&9 /%--) 9"6 +% 6'(#) !?I0 '&9 UgT0 1#2&21'# '&9 ('92%-('5,21 82&92&-0\ < U69 O65'+2C'+2%& < '#76%#2 #%06 +,62( #2&2&- '&9 '(6 5'1K69 :2+, !?I0A 82/(2&A '&9 UgT0 d0"'##) 2+ 20 $2#9 :2+, $2&2$'# 05"+"$ '&9 ' Z(6) O65'+2C'+2%& < @() '&9 82($ '8+6( (69 16##0 ,'76 /66& #)069A 6D"9'+6 (6$'2&0 #%: 8676( U60%#"+2%& < U6$%7'# %8 6D"9'+6 3(60%(5+2%&A 1%"-,A $'1(%5,'-604

]&9%-6&%"0 #2529 !IE Q @;4?*R/?7GJ 30676(2+) 96+6($2&69 /) =]cF4 6/6 < 1"5569 0,'569 1)0+0 :2+, 1%++%& 1'&9) 6D"9'+6 3R2(%76124 h I%($'# /&.5(5& < /"992&- )6'0+ :2+, 506"9%,)5,'6  !'-#,E($$1' < 065+'+6 ,)'#2&6 ,)5,'6 :2+, '1"+6 '&-#6 /('&1,2&-N 8%"( +)560 < 8"&-'# /'##A h Eg!E 3M-] '&9 ].P4A '&-2%2&7'0276 '056(-2##%020A %( &61(%+2C2&B%%K '+ ;BT < i Wjk < I%($'# H2E+02%#"#' < I%&G065+'+6 ,)'#2&6 ,)5,'6 :2+, (2-,+ '&-#6 /('&1,2&-A 066& 2& ?"1%( h 3@bE4A U,2C%5"0A '&9 E/0292' 055SN 5(692#61+2%& 8%( 2&7'92&- /#%%9 76006#0 < 2&8'(1+ l Wjk < U60+(21+276 / /$(.(%&$ 5(&E.+'(' < 5(%9"1+276 1%"-, 8%( '+ #6'0+ L 1%&061"+276 $%&+,0 %76( ' +:% )6'( @60+("1+2%& %8 +,6 '#76%#'( 0'10 < #%00 %8 6#'0+21 (61%2# 32S6S m 1%$5#2'&164 '&9 1%##'506 %8 +,6 56(2%9p 9682&69 /) $"1"0 ,)56(061(6+2%& '2(:')0 9"(2&- 6D52('+2%& < '2( +('552&@20+'# '2(05'160 /61%$6 6&#'(-69 -272&- ' $%+,G6'+6&Q05%&-) '556'('&16 +% +,6 #"&!(%9"1+276 1%"-, < [/"1K6+0 %8 $"1"0\ ;,6(6 20 &% '00%12'+69 82/(%020N 8(66 8#%'+2&- 065+' 066& %& $21(%01%5) O2-,#) '00%12'+69 :2+, 0$%K2&- < ,)56(+(%5,) '&9 ,)56(5#'02' %8 +,6 06(%$"12&%"0 -#'&90 3U629 2&96D 20 injkSSS &%($'# 20 lojk4A 0>"'$%"0 $6+'5#'02'A m -%/#6+ 16##0A '&9 M$/'#'&16 /6+:66& 5(%+6'060 '&9 '&+2G5(%+6'060 1%"5#69 :2+, 2&'96>"'+6 (65'2(a 2&8#'$$'+%() 16##0 3T@WqA ?'10A '&9 !?I0p &% ].P4 No eosinophils in contrast to asthma rF 1'"06 20 0$%K2&- 3%#.",(&%(.&,L$+:1$&, 4 < 6D1600276 0+2$"#'+2%& %8 !?IY0 '&9 ?'10N .& -(%00 2&0561+2%& +,6 '2(:')0 '(6 ,)56(6$21 '&9 0:%##6& $%0+#) '8861+0 +,6 (6052('+%() /(%&1,2%#60 2& +,6 "556( #%/6 sFG'&+2+()502& 9682126&1) 3-&.&%(.&,L$+:1$&, 4 < $208%#969 5(%+62& -6+0 0+"1K 2& +,6 ]U %8 T#2&21'##) 5(606&+0 :2+, +,6 1%"-, '&9 &% %+,6( (6052('+%() 9)08"&1+2%& ,65'+%1)+60 8%($2&- 52&K !EP q76 -('&"#60 3'#0% 1'"060 12((,%0204 P676(6 1'060a 1,(%&21 /(%&1,2%#2+20 :2+, -%/#6+ 16## $6+'5#'02' < '2(8#%: %/0+("1+2%& 32S6S ?%0+#) '8861+0 +,6 #%:6( #%/60 920+'# +% Ug 0$'## '2(:') 9206'064 < #"$2&'# &'((%:2&- 9"6 +% 82/(%020A $"1"0 '&9 2&8#'$$'+2%& !2??A !2?t %( !2tt 3'##6#60 '(6 #%1'+69 %& 1,(%$%0%$6 Fo4 Pi gene on 14 T%$5#21'+2%&0 < 6$5,)06$'A 2&861+2%& !%#)$%(5,20$0 2& ;Z=u '&9 ??! -6&60 1'& '#0% /6 2&7%#769 MMP= matrix metalloproteinases 6&,&'#-"&$ 6$5,)06$' 35('"&$ &%(.&,4 < %11"(0 &6D+ +% '+6#61+'020A 82/(%020A '&9 01'((2&-A ]D1600 $"1"0Q82/(%020 5#"-0 "5 +,6 /(%&1,2%#60 +('552&- T.^ 3m!'T.^A h!'.^4 :,21, 1'"060 $'(-2&0A 0"/5#6"('#A 6+1S $%(6 1%$$%&#) 2& +,6 "556( #%/6S T'& 8%($ /"##'6 '&9 !;V 6&,&%(%&",(%(&$ 32((6-"#'(4 6$5,)06$' 8%($0 &6'( ' 01'( '&9 20 '0)$5+%$'+21 ,)5%D6$2'A ,)56(1'5&2' '&9 1)'&%020 9"6 +% ' cQf $20$'+1, < (60%(5+2%& '+6#61+'020 O)5%D21 7'0%1%&0+(21+2%& < 5"#$%&'() O;I < Uc ='2#"(6 31%( 5"#$%&'#64 < 56(25,6('# 696$'

Overweight

 

T#2&21'# < 9)05&6' :2+, ' &%&G5(%9"1+276 39()4 1%"-,A 5(%#%&-69 6D52('+2%& :2+, 5"(069 #250A :62-,+ #%00A /'((6#G1,60+69 3m =UT4A 8#'++6&69 92'5,('-$ 066& %& TVUA &%($'# /#%%9 -' 2& +,6 ['1"+6\ 0+'-6N #'+6 1%$5#21'+2%&0 2&1#"96 ,)5%D6$2' '&9 1%( 5"#$%&'#6 Slim

Aspirin causes asthma symptoms cuz it blocks cox pathway but not lipooxygenase pathway favoring leukotrieenes and brochospasm

!"#$%&'() !'+,%#%-)

Birbrck granules= little tennis racket.. Pulmonary langerhan cell histiocytosis..and eosinop granuloma Eosinophilic granuloma?

 !'"